Payments to Acquire Property, Plant, and Equipment of Aclaris Therapeutics, Inc. from 31 Dec 2014 to 31 Mar 2025

Taxonomy & unit
us-gaap: USD
Description
The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.
Summary
Aclaris Therapeutics, Inc. quarterly and annual Payments to Acquire Property, Plant, and Equipment in USD history and change rate from 31 Dec 2014 to 31 Mar 2025.
  • Aclaris Therapeutics, Inc. Payments to Acquire Property, Plant, and Equipment for the quarter ending 31 Mar 2025 was $43,000, a 68% decline year-over-year.
  • Aclaris Therapeutics, Inc. annual Payments to Acquire Property, Plant, and Equipment for 2024 was $121,000, a 91% decline from 2023.
  • Aclaris Therapeutics, Inc. annual Payments to Acquire Property, Plant, and Equipment for 2023 was $1,309,000, a 116% increase from 2022.
  • Aclaris Therapeutics, Inc. annual Payments to Acquire Property, Plant, and Equipment for 2022 was $605,000, a 96% increase from 2021.
Source SEC data
View on sec.gov
Payments to Acquire Property, Plant, and Equipment, Quarterly (USD)
Payments to Acquire Property, Plant, and Equipment, YoY Quarterly Change (%)
Payments to Acquire Property, Plant, and Equipment, Annual (USD)
Payments to Acquire Property, Plant, and Equipment, YoY Annual Change (%)

Aclaris Therapeutics, Inc. Quarterly Payments to Acquire Property, Plant, and Equipment (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q1 2025 $43,000 -$92,000 -68% 01 Jan 2025 31 Mar 2025 10-Q 08 May 2025 2025 Q1
Q1 2024 $135,000 -$418,000 -76% 01 Jan 2024 31 Mar 2024 10-Q 08 May 2025 2025 Q1
Q1 2023 $553,000 +$389,000 +237% 01 Jan 2023 31 Mar 2023 10-Q 07 May 2024 2024 Q1
Q1 2022 $164,000 01 Jan 2022 31 Mar 2022 10-Q 08 May 2023 2023 Q1
Q1 2020 $124,000 -$160,000 -56% 01 Jan 2020 31 Mar 2020 10-Q 07 May 2021 2021 Q1
Q1 2019 $284,000 -$14,000 -4.7% 01 Jan 2019 31 Mar 2019 10-Q 07 May 2020 2020 Q1
Q1 2018 $298,000 +$103,000 +53% 01 Jan 2018 31 Mar 2018 10-Q 08 May 2019 2019 Q1
Q1 2017 $195,000 +$155,000 +388% 01 Jan 2017 31 Mar 2017 10-Q 08 May 2018 2018 Q1
Q1 2016 $40,000 -$37,000 -48% 01 Jan 2016 31 Mar 2016 10-Q 09 May 2017 2017 Q1
Q1 2015 $77,000 01 Jan 2015 31 Mar 2015 10-Q 11 May 2016 2016 Q1

Aclaris Therapeutics, Inc. Annual Payments to Acquire Property, Plant, and Equipment (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2024 $121,000 -$1,188,000 -91% 01 Jan 2024 31 Dec 2024 10-K 27 Feb 2025 2024 FY
2023 $1,309,000 +$704,000 +116% 01 Jan 2023 31 Dec 2023 10-K 27 Feb 2025 2024 FY
2022 $605,000 +$297,000 +96% 01 Jan 2022 31 Dec 2022 10-K 27 Feb 2024 2023 FY
2021 $308,000 -$145,000 -32% 01 Jan 2021 31 Dec 2021 10-K 27 Feb 2024 2023 FY
2020 $453,000 -$1,160,000 -72% 01 Jan 2020 31 Dec 2020 10-K 23 Feb 2023 2022 FY
2019 $1,613,000 +$257,000 +19% 01 Jan 2019 31 Dec 2019 10-K 24 Feb 2022 2021 FY
2018 $1,356,000 +$121,000 +9.8% 01 Jan 2018 31 Dec 2018 10-K 25 Feb 2021 2020 FY
2017 $1,235,000 +$1,003,000 +432% 01 Jan 2017 31 Dec 2017 10-K 25 Feb 2020 2019 FY
2016 $232,000 -$275,000 -54% 01 Jan 2016 31 Dec 2016 10-K 18 Mar 2019 2018 FY
2015 $507,000 +$90,000 +22% 01 Jan 2015 31 Dec 2015 10-K 12 Mar 2018 2017 FY
2014 $417,000 01 Jan 2014 31 Dec 2014 10-K 15 Mar 2017 2016 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.